Ampio Pharmaceuticals, Inc. (AMPE)

USD 0.0

(0.0%)

Long Term Debt Summary of Ampio Pharmaceuticals, Inc.

  • Ampio Pharmaceuticals, Inc.'s latest annual long term debt in 2023 was - USD , down -100.0% from previous year.
  • Ampio Pharmaceuticals, Inc.'s latest quarterly long term debt in 2023 FY was - USD , down -100.0% from previous quarter.
  • Ampio Pharmaceuticals, Inc. reported annual long term debt of 274 Thousand USD in 2022, down -55.37% from previous year.
  • Ampio Pharmaceuticals, Inc. reported annual long term debt of 614 Thousand USD in 2021, down -33.62% from previous year.
  • Ampio Pharmaceuticals, Inc. reported quarterly long term debt of - USD for 2023 Q4, down 0.0% from previous quarter.
  • Ampio Pharmaceuticals, Inc. reported quarterly long term debt of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Ampio Pharmaceuticals, Inc. (2023 - 2006)

Historical Annual Long Term Debt of Ampio Pharmaceuticals, Inc. (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 - USD -100.0%
2022 274 Thousand USD -55.37%
2021 614 Thousand USD -33.62%
2020 925 Thousand USD -23.55%
2019 1.21 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 4.92 Million USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Long Term Debt Comparison of Ampio Pharmaceuticals, Inc.

Name Long Term Debt Long Term Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD 100.0%
Armata Pharmaceuticals, Inc. 82.3 Million USD 100.0%
Actinium Pharmaceuticals, Inc. 1.57 Million USD 100.0%
Azitra, Inc. 563.69 Thousand USD 100.0%
Can-Fite BioPharma Ltd. 13 Thousand USD 100.0%
Chromocell Therapeutics Corporation - USD NaN%
Calidi Biotherapeutics, Inc. 2.06 Million USD 100.0%
CEL-SCI Corporation 11.6 Million USD 100.0%
iBio, Inc. 3.5 Million USD 100.0%
Lineage Cell Therapeutics, Inc. 2.07 Million USD 100.0%
MAIA Biotechnology, Inc. - USD NaN%
Matinas BioPharma Holdings, Inc. 2.89 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD 100.0%
NovaBay Pharmaceuticals, Inc. 1.1 Million USD 100.0%
NanoViricides, Inc. - USD NaN%
Oragenics, Inc. - USD NaN%
BiomX Inc. 5.4 Million USD 100.0%
BiomX Inc. 5.4 Million USD 100.0%
Protalix BioTherapeutics, Inc. 4.62 Million USD 100.0%
Palatin Technologies, Inc. 163.78 Thousand USD 100.0%
Scorpius Holdings, Inc. 12.61 Million USD 100.0%